Diazepam Use for Skeletal Muscle Spasm
Diazepam (Valium) is a benzodiazepine that has FDA labeling support as an adjunct for skeletal muscle spasm due to reflex spasm from local pathology, such as inflammation or trauma. [1] Major low back pain guidelines advise avoiding benzodiazepines because they have not shown added benefit over standard therapy and carry risk of adverse effects. [2]
FDA-Approved Role for Muscle Spasm
Diazepam is labeled as a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology, such as inflammation of the muscles or joints, or secondary to trauma. [1] Diazepam is also labeled as adjunctive therapy for spasticity from upper motor neuron disorders and for stiff-man syndrome. [1]
Guideline Position for Acute Low Back Pain
For acute low back pain, benzodiazepines are recommended to be avoided in guideline-based care because diazepam added to naproxen does not improve pain or function compared with naproxen alone. [2] For chronic low back pain, evidence does not show benefit of diazepam over placebo. [2]
Selection Considerations for “Muscle Relaxant” Use
Benzodiazepines are not considered typical first-line muscle relaxants for nonspecific back pain syndromes. [2] Non-benzodiazepine muscle relaxants are suggested over benzodiazepines when a muscle relaxant is considered for short-term use in acute low back pain. [3]
Treatment Thresholds and Duration Considerations
When diazepam is used for labeled muscle spasm indications, reassessment of usefulness is required because long-term effectiveness has not been assessed beyond about 4 months in systematic studies. [1]
Safety and Risk Considerations
Benzodiazepines carry risks of abuse, misuse, physical dependence, and withdrawal, which increase the clinical concern for use in pain syndromes. [4] Avoidance in low back pain is supported by lack of benefit and risk considerations consistent with benzodiazepine safety communications. [2][4]
Common Pitfalls to Avoid
Using diazepam as a routine “muscle relaxant” for low back pain is discouraged because guideline recommendations state that benzodiazepines should be avoided and diazepam does not provide added improvement over naproxen for acute low back pain. [2] Prolonged use without documented benefit is a pitfall because long-term effectiveness beyond 4 months has not been established in systematic clinical studies. [1]
Practical Clinical Implication
Diazepam can be used for labeled skeletal muscle spasm in appropriate clinical contexts as an adjunct therapy. [1] Diazepam is generally avoided for low back pain syndromes because benefit is not demonstrated over standard therapy and benzodiazepine risks are clinically important. [2]